English | Español

Takeda Pharmaceutical Company
Press release submission | Jun 19, 2018

TAKEDA PHARMACEUTICAL COMPANY: Takeda Further Expands Help At Hand Patient Assistance Program in U.S.

Robert Hadley | May 21, 2017

Three years of outcomes show Entyvio tames irritable bowel disease 
Gene Johnson | Mar 10, 2017

Takeda, Cognition Kit launch app to monitor patients with major depressive disorder
Carol Ostrow | Dec 31, 2016

Takeda takes top spot for LGBT-friendly workplace
Amanda Rupp | Nov 2, 2016

Takeda highlights commitment to fighting Hodgkin lymphoma
Caitlin Nordahl | Aug 17, 2016

Takeda, Ultragenyx to partner for therapy development
Amanda Rupp | Jun 24, 2016

Takeda gains Gates Foundation grant for polio efforts in developing countries
Caitlin Nordahl | Jun 19, 2016

Takeda, Theravance enter license deal for gastrointestinal motility disorder treatment

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’